Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 19c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($1.06), $0.19 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $63 million versus the consensus estimate of $51.58 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Raymond James Starts Mid Penn Bancorp (MPB) at Outperform
• BofA Securities Downgrades Fox Factory Holding (FOXF) to Underperform